COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 3115: Articles 31141-31150  | Next

Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies
Ahmed, S. F., Quadeer, A. A., McKay, M. R.
10.1101/2020.02.03.933226 — Posted: 2020-02-04 Discussion: Onsite
Machine learning-based analysis of genomes suggests associations between Wuhan 2019-nCoV and bat Betacoronaviruses
Randhawa, G. S., Soltysiak, M. P. M., El Roz, H., de Souza, C. P. E., Hill, K. A., Kari, L.
10.1101/2020.02.03.932350 — Posted: 2020-02-04
Machine intelligence design of 2019-nCoV drugs
Nguyen, D. D., Gao, K., Wang, R., Wei, G.
10.1101/2020.01.30.927889 — Posted: 2020-02-04
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., Cai, J., Fan, J., Lan, F.
10.1101/2020.02.03.931766 — Posted: 2020-02-04 Discussion: Onsite | Offsite
Phylogenomic analysis of the 2019-nCoV coronavirus
Ceraolo, C., Giorgi, F. M.
10.1101/2020.02.02.931162 — Posted: 2020-02-04 Discussion: Onsite
Direct Measurement of Rates of Asymptomatic Infection and Clinical Care-Seeking for Seasonal Coronavirus
Shaman, J., Galanti, M.
10.1101/2020.01.30.20019612 — Posted: 2020-02-03
Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)
Huang, Q., Herrmann, A.
10.1101/2020.02.01.930537 — Posted: 2020-02-03
Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases
Lin, S., Shen, R., Guo, X.
10.1101/2020.01.31.929695 — Posted: 2020-02-03
Transmission and epidemiological characteristics of Novel Coronavirus (2019-nCoV)-Infected Pneumonia(NCIP):preliminary evidence obtained in comparison with 2003-SARS
Zhang, R., Liu, H., Li, F., Zhang, B., Liu, Q., Li, X., Luo, L.
10.1101/2020.01.30.20019836 — Posted: 2020-02-02
Real time estimation of the risk of death from novel coronavirus (2019-nCoV) infection: Inference using exported cases
Jung, S.-m., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., Kobayashi, T., Kinoshita, R., Nishiura, H.
10.1101/2020.01.29.20019547 — Posted: 2020-02-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).